Canopy Growth (CGC) Treasury Shares (2018 - 2026)
Canopy Growth (CGC) posted Treasury Shares of $2.1 million for Q1 2026, down 5.67% sequentially from $2.3 million in Q4 2025, and up 124.91% YoY from $947586.9 in Q1 2025.
Canopy Growth (CGC) Treasury Shares (2018 - 2026) Analysis & Trends
Canopy Growth has reported Treasury Shares for 9 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Treasury Shares rose 124.91% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 124.91% YoY) and the FY2026 annual result came in at $2.1 million, up 124.91% from the prior year.
- Treasury Shares slipped to $2.1 million in Q1 2026 per CGC's latest filing, from $2.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $11.5 million in Q3 2023 and troughed at $191079.8 in Q1 2023.
- A 5-year average of $2.4 million and a median of $1.3 million in 2024 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 394.13% in 2024, down 90.63% in 2024.
- Over 5 years, Treasury Shares stood at $3.2 million in 2022, then sank by 67.67% to $1.0 million in 2023, then decreased by 0.1% to $1.0 million in 2024, then soared by 119.73% to $2.3 million in 2025, then dropped by 5.67% to $2.1 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $2.1 million, $2.3 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 19.00 Mn |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.39 Mn |
| Jun 30, 2026 | 6.39 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 947,586.88 |
| Mar 31, 2025 | 947,586.88 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 944,189.89 |
| Mar 31, 2024 | 944,189.89 |